查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1584735

過敏疫苗市場：按過敏類型、疫苗類型、應用、最終用戶分類 - 全球預測 2025-2030

Allergy Vaccine Market by Allergy Type, Vaccine Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年過敏疫苗市值為12.8億美元，預計2024年將達14.3億美元，複合年成長率為11.51%，到2030年將達27.5億美元。

過敏疫苗市場包括透過使免疫系統對過敏原脫敏來治療或預防過敏反應而開發的疫苗。該市場包括各種類型的疫苗，例如皮下免疫療法（SCIT）和舌下免疫療法（SLIT），主要針對花粉、塵蟎和食物過敏原等過敏。過敏疫苗的需求源自於全世界過敏性疾病的日益流行，這些疾病影響數百萬人，並對生活品質和醫療保健系統產生重大影響。這些疫苗的應用對於控制症狀和降低嚴重過敏反應的風險至關重要，使其在臨床環境和過敏患者的日常管理中都很有價值。最終用途範圍包括醫院、診所和家庭的彈性治療。推動成長的關鍵因素包括對過敏性疾病認知的提高、生物技術的進步以及政府支持免疫治療研究的舉措。新的商機在於個人化疫苗，利用基因組學根據個人免疫特徵客製化治療方法。生物技術公司和醫療保健提供者之間的合作可以促進更快的創新和採用，並確保可及性和可負擔性。然而，市場成長面臨嚴格的監管途徑、研發成本高以及新興市場認知度和接受度低等限制。此外，副作用和長期療效的問題可能會讓一些患者望而卻步。為了解決這些問題，需要加強並廣泛接受有關利益和風險的教育宣傳活動。研究和創新可以集中在增強疫苗輸送方法，包括研究奈米顆粒技術以提高療效和患者依從性。此外，解決鮮為人知的過敏類型，例如環境過敏原和化學過敏原，可能會擴大治療範圍。因此，這些領域的創新需要在技術力和策略市場教育之間取得平衡，以推動接受並克服挑戰，以確保在全球過敏症患者數量不斷成長的背景下取得穩步進展。

主要市場統計
基準年[2023] 12.8億美元
預測年份 [2024] 14.3億美元
預測年份 [2030] 27.5億美元
複合年成長率（%） 11.51%

市場動態：揭示快速發展的過敏疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變過敏疫苗市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球過敏流行率不斷上升
    • 工業化導致空氣污染加劇
    • 提高消費者對過敏的認知
  • 市場限制因素
    • 有限的過敏疫苗生產商
  • 市場機會
    • 特定過敏疫苗生產研發
    • 政府和私營部門在疫苗生產上的努力
  • 市場挑戰
    • 過敏疫苗的生產是資本集中的

波特五力：駕馭過敏疫苗市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解過敏疫苗市場的外部影響

外部宏觀環境因素對影響過敏疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解過敏疫苗市場的競爭狀況

過敏疫苗市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣過敏疫苗市場供應商的績效評估

FPNV 定位矩陣是評估過敏疫苗市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了過敏疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，過敏疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球過敏盛行率正在上升
      • 工業化導致空氣污染加劇
      • 提高消費者對過敏的認知
    • 抑制因素
      • 有限過敏疫苗製造商
    • 機會
      • 特定過敏疫苗生產的研發
      • 政府和私營部門在疫苗生產上的努力
    • 任務
      • 過敏疫苗的生產是資本集中的
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章過敏疫苗市場：依過敏類型

  • 過敏性氣喘
  • 貓皮屑過敏
  • 草花粉敏感度
  • 花生過敏
  • 季節性過敏性鼻炎
  • 樹花粉過敏

第7章過敏疫苗市場：依疫苗類型

  • 貓過敏疫苗
  • 屋塵蟎過敏疫苗
  • 注射型 MPL 過敏疫苗
  • 花生過敏疫苗
  • 豚草過敏免疫療法疫苗

第8章過敏疫苗市場：依應用分類

  • HIV
  • 腫瘤學
  • 呼吸系統

第9章過敏疫苗市場：依最終用戶分類

  • 居家護理
  • 醫院
  • 專科診所

第10章美洲過敏疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太過敏疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲過敏疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ALK-Abello, Inc.
  • Allergy Therapeutics PLC
  • Angany Inc.
  • Astellas Pharma Inc.
  • Biomay AG
  • DBV Technologies SA
  • Enesi Pharma Limited
  • Immunomic Therapeutics, Inc.
  • Jubilant Pharma Limited
  • LETI Pharma, SLU
  • Merck & Co., Inc.
  • Novartis AG
  • Sementis Ltd.
  • Stallergenes Greer International AG
  • Sunstone by Anergis SA
  • Thermo Fisher Scientific Inc.
Product Code: MRR-436901065A74

The Allergy Vaccine Market was valued at USD 1.28 billion in 2023, expected to reach USD 1.43 billion in 2024, and is projected to grow at a CAGR of 11.51%, to USD 2.75 billion by 2030.

The allergy vaccine market involves vaccines developed to treat or prevent allergic reactions by desensitizing the immune system to allergens. This market encompasses various vaccine types, such as subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), primarily addressing allergies like pollen, dust mites, and food allergens. The necessity for allergy vaccines is driven by the increasing prevalence of allergic disorders globally, which affect millions and significantly impact the quality of life and healthcare systems. The application of these vaccines is crucial in managing symptoms and reducing the risk of severe allergic reactions, making them valuable in both clinical settings and everyday management for allergy sufferers. The end-use scope includes hospitals, clinics, and home settings for treatment flexibility. Key factors catalyzing growth include heightened awareness of allergic conditions, advances in biotechnology, and government initiatives supporting immunotherapy research. Emerging opportunities lie in personalized vaccines, leveraging genomics to tailor treatments to individual immune profiles. Collaborations between biotech firms and healthcare providers can facilitate faster innovation and adoption, ensuring accessibility and affordability. However, market growth faces limitations such as stringent regulatory pathways, high R&D costs, and limited awareness or acceptance in emerging markets. Additionally, side effects and long-term efficacy questions may deter some patients. Addressing these could involve increasing educational campaigns about allergy vaccine benefits and risks to broaden acceptance. Research and innovation could focus on enhancing vaccine delivery methods, such as exploring nanoparticle technologies for improved efficacy and patient compliance. There's also potential in addressing under-represented allergy types, like environmental and chemical allergens, expanding treatment horizons. Consequently, innovating in these areas will require a balance of technical prowess and strategic market education to drive acceptance and overcome challenges, ensuring steady market growth against the backdrop of increasing global allergic incidences.

KEY MARKET STATISTICS
Base Year [2023] USD 1.28 billion
Estimated Year [2024] USD 1.43 billion
Forecast Year [2030] USD 2.75 billion
CAGR (%) 11.51%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Vaccine Market

The Allergy Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of allergies globally
    • Increasing air pollution with industrialization
    • Rising awareness among consumers about the allergies
  • Market Restraints
    • Limited allergy vaccine manufacturers
  • Market Opportunities
    • Research and development for the production of specific allergy vaccine
    • Government and private sector initiatives in the production of vaccines
  • Market Challenges
    • Capital intensive in the production of allergy vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Vaccine Market

A detailed market share analysis in the Allergy Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Vaccine Market

A strategic analysis of the Allergy Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Vaccine Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello, Inc., Allergy Therapeutics PLC, Angany Inc., Astellas Pharma Inc., Biomay AG, DBV Technologies SA, Enesi Pharma Limited, Immunomic Therapeutics, Inc., Jubilant Pharma Limited, LETI Pharma, S.L.U., Merck & Co., Inc., Novartis AG, Sementis Ltd., Stallergenes Greer International AG, Sunstone by Anergis SA, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Allergy Type, market is studied across Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity, Peanut Hypersensitivity, Seasonal Allergic Rhinitis, and Tree Pollen Hypersensitivity.
  • Based on Vaccine Type, market is studied across Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine, Peanut Allergy Vaccine, and Ragweed Allergy Immunotherapy Vaccine.
  • Based on Application, market is studied across HIV, Oncology, and Respiratory.
  • Based on End User, market is studied across Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of allergies globally
      • 5.1.1.2. Increasing air pollution with industrialization
      • 5.1.1.3. Rising awareness among consumers about the allergies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited allergy vaccine manufacturers
    • 5.1.3. Opportunities
      • 5.1.3.1. Research and development for the production of specific allergy vaccine
      • 5.1.3.2. Government and private sector initiatives in the production of vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Capital intensive in the production of allergy vaccines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Allergy Vaccine Market, by Allergy Type

  • 6.1. Introduction
  • 6.2. Allergic Asthma
  • 6.3. Cat Dander Allergy
  • 6.4. Grass Pollen Hypersensitivity
  • 6.5. Peanut Hypersensitivity
  • 6.6. Seasonal Allergic Rhinitis
  • 6.7. Tree Pollen Hypersensitivity

7. Allergy Vaccine Market, by Vaccine Type

  • 7.1. Introduction
  • 7.2. Cat Allergy Vaccine
  • 7.3. House Dust Mite Allergy Vaccine
  • 7.4. Injectable MPL Allergy Vaccine
  • 7.5. Peanut Allergy Vaccine
  • 7.6. Ragweed Allergy Immunotherapy Vaccine

8. Allergy Vaccine Market, by Application

  • 8.1. Introduction
  • 8.2. HIV
  • 8.3. Oncology
  • 8.4. Respiratory

9. Allergy Vaccine Market, by End User

  • 9.1. Introduction
  • 9.2. Homecare
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Americas Allergy Vaccine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Allergy Vaccine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Allergy Vaccine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ALK-Abello, Inc.
  • 2. Allergy Therapeutics PLC
  • 3. Angany Inc.
  • 4. Astellas Pharma Inc.
  • 5. Biomay AG
  • 6. DBV Technologies SA
  • 7. Enesi Pharma Limited
  • 8. Immunomic Therapeutics, Inc.
  • 9. Jubilant Pharma Limited
  • 10. LETI Pharma, S.L.U.
  • 11. Merck & Co., Inc.
  • 12. Novartis AG
  • 13. Sementis Ltd.
  • 14. Stallergenes Greer International AG
  • 15. Sunstone by Anergis SA
  • 16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ALLERGY VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGY VACCINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ALLERGY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALLERGY VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGY VACCINE MARKET DYNAMICS
  • TABLE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. ALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. ALLERGY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023